Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?

Agillic – Presentation of Q1 2025 results

Af HC Andersen Capital
Agillic

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Agillic expects to report its Q1 2025 results on the 7th of May 2025. The same day at 11:00, Agillic’s management will present the results, update on market conditions, and answer questions in an online live event.

2024 ended with a total ARR of DKK 65.5m (2023: ARR of DKK 70.1m) and a revenue of DKK 60m (2023: DKK 64.7m). Despite a decrease in gross profit of DKK 3.2 million as well as one-time costs for consultancy fees and severance costs of total DKK 3.1 million, 2024 EBITDA ended positively at DKK 1.0 million (2023: DKK 1.9 million).

For 2025, Agillic expects revenue in the range of DKK 60-63m and an EBITDA of DKK 5-8m. ARR from subscriptions is expected to grow to DKK 56-60m.

Besides the financial Q1 2025 results and how they track vs. the full year guidance, the focus could be on comments regarding the progress of the new strategy. A strategy, which includes a more focused marketing strategy, focusing on the Nordic markets, and ambitions to speed up product releases.

Agillic is a Danish SaaS company offering B2C companies a customer engagement platform that empowers them to create data-driven, personalized customer experiences to differentiate against their competitors.

Disclaimer: HC Andersen Capital receives payment from Agillic for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 12.02, 12-04-2025.

Seneste videoer

Incap India’s production and testing director interviewed
14.11.2025, 15.10 Incap
AKTIER MED FRIIS - UGE 46 2025
14.11.2025, 12.00
NIBE, Audiocast, Q3'25
14.11.2025, 11.00 Nibe Industrier
Egetis Therapeutics, Audiocast, 2025
14.11.2025, 10.00 Egetis Therapeutics
HCA Morgenbørs 14/11 - Overvejende negative markeder og fokus på Bavarian Nordic
14.11.2025, 09.26 Novo Nordisk
Vis alle videoer
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.